54
6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process assessment Clinical challenges Jeffrey Barber, Medical Physicist IAEA RAS6065, Singapore Dec 2012

6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Embed Size (px)

Citation preview

Page 1: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QAEquipment specific QAIn vivo DosimetryTG-142 and TG-101 guidelinesProcess assessmentClinical challenges

Jeffrey Barber, Medical PhysicistIAEA RAS6065, Singapore Dec 2012

Page 2: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

2

Useful References

• AAPM TG-101 Report: SBRT• AAPM TG-142 Report: Medical Linac QA• AAPM TG-179 Report: CT-based IGRT QA

Page 3: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process
Page 4: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

0.5mm gantry locus

2mm image

reg

2mm immob

movement

0.5mm kV-MV

1mm laser loc

2mm couch locus

2mm contouring variation

10mm target

respiratory motion

3% dose delivery

Page 5: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Quality Assurance

• Physicists should check individual parameters and combined processes

• If you check everything in isolation, how do you know what you are doing at the end

• TG-142 and TG-101 are guidelines. Lots of advice on how to do things, how to investigate and how to develop local protocol

• The future TG-100 proposes a different approach

Page 6: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

QA Approach• Perks et al (2012) IJROBP 83 p1324 • Fault Mode Effects Analysis (FMEA) • Process Engineering concept used to

focus QA efforts on most practical problems

1. Map your processes (flowchart, tree, etc)

2. Give any foreseeable fault a weighted score• likelihood of Occurrence• Severity of fault• likelihood of being Detected

3. Then add QA processes to address the potential faults, with most effort focused on highest scores

Page 7: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

QA Approach

Page 8: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

8

QA Approach

• FMEA promises to increase the efficiency and effectiveness of the testing required

• But FMEA takes a lot of resources and time to set up

• Current guidelines are effective, if intensive

• Quality Assurance can be categorised as:• Equipment QA• Patient-specific QA

Page 9: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

9

EQUIPMENT QA

Page 10: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA

• TG-142 Daily

Page 11: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA

• TG-142 Monthly

Page 12: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA

• TG-142 Annual (1)

Page 13: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA

• TG-142 Annual (2)

Page 14: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA

• TG-142 MLC

Page 15: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA

• TG-142 Imaging (1)

Page 16: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA

• TG-142 Imaging (2)

Page 17: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

17

Equipment QA

• ASTRO

Page 18: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA

• TG-101

Page 19: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA

• TG-101

Page 20: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA

• TG-101

Page 21: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA

• TG-101

Page 22: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA – kV/MV coincidence

Room Lasers

Imaging Isocentre

Radiation Isocentre

Page 23: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA – kV/MV coincidence

Room Lasers

Imaging Isocentre

Radiation Isocentre

Page 24: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA – kV/MV coincidence

• Winston-Lutz type tests check centre points

Page 25: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA – kV/MV coincidence

Sharpe et al, Med. Phys. 33, 136-144, 2006

Page 26: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA – kV/MV coincidence

• Elekta: Planar images are uncorrected. Flexmap offset saved in DICOM header. 3D reconstructions include the correction.

• Varian: Flex is included in robotic arm so each image is corrected.

• If flex needs calibrating, it will be visible in the reconstructed images Bissonnette

Page 27: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Equipment QA – Daily Checks

• Daily IGRT QA1. Set up phantom with known offset2. Image, register, check offset is right3. Correct couch, re-image, check residual error4. Visually inspect the new phantom position

Page 28: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

28

Equipment QA – Image Quality

Rings

Capping

Streaks

Motion

Page 29: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

29

Equipment QA – Image Quality

• Most important Image Quality parameter is spatial accuracy and scaling

Page 30: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

30

Equipment QA – Image Quality

• Most important Image Quality parameter is spatial accuracy and scaling

Page 31: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Machine QA – MLC Accuracy

• Using Picket Fence and Garden Fence beams• Film• EPID• Array Device

• Analysis is the hard part• How good is your eye?• How good is your image processing?• Lots of commercial solutions available

Page 32: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Machine QA – MLC Accuracy

Page 33: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

33

PATIENT-SPECIFIC QA

Page 34: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Patient Specific QA

high doses+ small volumes+ complex beam arrangements+ moving structures= need for patient-specific QA

• Verify Dose

• Verify 3D Distribution

Page 35: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Patient Specific QA

• Verify Dose• Copy plan to phantom, recalculate, deliver to

chamber

• Chamber measurements ≤ 3% from planned dose

• Array devices and film can be calibrated to dose

Page 36: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Patient Specific QA

• Verify Distribution• Array devices (MapCheck, ArcCheck, Matrixx,

Octavius, Delta4, etc.)• Film• Gel?

• Use Record/Verify “QA Mode” deliver at true gantry angles.

• Analyse beams individually and as whole fraction.

Page 37: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Patient-Specific QA (Pre-Tx)• Using the Delta4 phantom we get psuedo-3D distribution of

points across the plan volume

• Two 2D planes of diodes form a cross

• Real plan > copy to phantom CT, recalc > measure > analyse

• Results are highly reproducible

Page 38: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Delta4 Results

Page 39: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Delta4 Results

• Halo distribution • TPS pumping dose in the

non-lateral-equilibrium regions

• Absolute dose max ~200% patient prescription• Difference of dose

absorption between high and low density mediums

Page 40: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Delta4 Results• Very similar results when measurements are repeated on same

day and different day reproducible delivery by MLC• Very similar results when measurements are repeated on

different linacs well matched and stable linacs

• Where to set tolerance for pass/fail?

Avg γ Pass 3mm DTA 2mm DTA 1mm DTA

Dose Diff 3% 100.0% 99.5% 93.1%

Dose Diff 2% 99.5% 96.0% 88.9%

Dose Diff 1% 97.9% 95.5% 77.5%

Page 41: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

More QA Equipment

Tomas Kron, Peter MacCallum Cancer Centre

Page 42: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Patient-Specific QA (Post-Tx)

• Phantom measurements check one delivery, one time.

• Linac log files can be used to check actual treatment delivery mechanical parameters

• Combine this with IGRT and dose reconstruction/accumulation is possible

Page 43: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Patient-Specific QA (Post-Tx)• Elekta does not have dynalogs • But a record of mechanical parameters is sent to Mosaiq after delivery• A report can be generated and compared to the DICOM-RTPlan

Page 44: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

In vivo Dosimetry

• TLD• OSLD• Diodes• MOSFETS• Radiochromic film squares

• “Ex vivo” Dosimetry• Transit Dosimetry via EPID• Per fraction beam fluence measurements

• Recommend checking in field and out of field

Page 45: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

45

In vivo Dosimetry

Page 46: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

46

PROCESS REVIEW

Page 47: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Process Evaluation

Page 48: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Process Evaluation

• MARGINPTV = 2.5Σ + 0.7σ

• Σ – st dev of sys errors• σ – st dev of random errors

• 2.5 and 0.7 come from 90% and 95% confidence intervals for Gaussian distributions, respectively.

• This margin has the 95% isodose line cover the CTV in 90% of patients

• Systematic errors contribute more than random errors to uncertainty

• 4DCT and IGRT should remove systematic error and reduce random error

Page 49: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Process Evaluation

Van Herk 2012

Page 50: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Process Evaluation

For a single patient:

• Systematic Error = mean offset

• Random Error = standard deviation

Chris Fox, Peter MacCallum

Page 51: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

Process Evaluation

For a population of patients:

• Systematic Error = standard deviation of individual mean errors

• Random Error = Root-Mean-Sum of individual random errors

Chris Fox, Peter MacCallum

Litt

le S

igm

aBi

g Si

gma

Page 52: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

52

Process Evaluation

• You can only collect statistics on what you image.

• If you want to know how accurate your IGRT is, you need another image after any couch shift

Page 53: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

THANK YOUTomas KronSimon DownesSean White

53

Page 54: 6. CLINICAL IMPLEMENTATION AND SBRT QUALITY ASSURANCE Patient Specific QA Equipment specific QA In vivo Dosimetry TG-142 and TG-101 guidelines Process

54